All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Insights on Cardiogenic Shock Early Detection and Risk Classification

Stephen Yolonda*

Department of Nursing, Zagazig University address, Shaibet an Nakareyah, Zagazig 2, Ash Sharqia Governorate 7120001, Egypt

*Corresponding Author:
Stephen Yolonda
Department of Nursing, Zagazig University address, Shaibet an Nakareyah, Zagazig 2, Ash Sharqia Governorate 7120001, Egypt

Received: 01 February, 2023, Manuscript No. jnhs-23-94798; Editor Assigned: 03 February, 2023, Pre QC No. P-94798; Reviewed: 15 February, 2023, QC No. Q-94798; Revised: 21 February, 2023, Manuscript No. R-94798; Published: 28 February, 2023, DOI: 10.4172/JNHS.2023.9.2.70

Visit for more related articles at Research & Reviews: Journal of Nursing and Health Sciences.


Cardiogenic shock is a life-threatening condition in which the heart fails to pump sufficient blood to meet the metabolic demands of the body. This can occur as a result of a variety of conditions, including acute myocardial infarction, severe valvular heart disease, myocarditis, and cardiomyopathy. In this essay, we will discuss the causes, symptoms, diagnosis, and treatment of cardiogenic shock. The most common cause of cardiogenic shock is acute myocardial infarction, also known as a heart attack. This occurs when a blockage in one or more of the coronary arteries restricts blood flow to the heart muscle, leading to damage or death of the heart muscle cells. Other causes of cardiogenic shock include severe valvular heart disease, such as aortic stenosis or mitral regurgitation, myocarditis, or inflammation of the heart muscle, and cardiomyopathy, a condition in which the heart muscle becomes weakened and enlarged.


Cardiogenic shock, Myocardial infarction, Myocarditis


The diagnosis of cardiogenic shock is made based on the patient's medical history, physical examination, and diagnostic tests. The patient's medical history may include information about any underlying medical conditions or recent events that may have contributed to the development of cardiogenic shock, such as a heart attack or valvular heart disease. A physical examination may reveal signs of shock, such as low blood pressure, rapid or weak pulse, and cool, clammy skin. Diagnostic tests may include an electrocardiogram (ECG), which can detect abnormalities in the heart's electrical activity, and blood tests, which can detect markers of heart muscle damage or inflammation. Imaging tests, such as echocardiography or cardiac MRI, may also be used to evaluate the structure and function of the heart [1-3].

The symptoms of cardiogenic shock are similar to those of other types of shock, such as hypovolemic shock or septic shock, but they are generally more severe. These symptoms may include:

Low blood pressure: A decrease in blood pressure is a common symptom of cardiogenic shock. This can cause lightheadedness, dizziness, and fainting.

Rapid or weak pulse: The heart may beat faster or slower than normal, or the pulse may be weak or irregular.

Shortness of breath: The lungs may not be getting enough oxygen, leading to shortness of breath or difficulty breathing.

Chest pain: Chest pain or discomfort may occur, especially in cases of myocardial infarction. Confusion or altered mental status: Decreased blood flow to the brain can cause confusion, disorientation, or loss of consciousness.

Pale, cool, or clammy skin: The skin may appear pale, cool, or clammy due to decreased blood flow.

Literature Review

The treatment of cardiogenic shock depends on the underlying cause and severity of the condition. The primary goal of treatment is to restore blood flow to the vital organs, including the heart, brain, and kidneys, and to improve cardiac function. Initial treatment may include oxygen therapy, fluid resuscitation, and medications to support blood pressure and cardiac function. In cases of myocardial infarction, reperfusion therapy, such as percutaneous coronary intervention (PCI) or thrombolytic therapy, may be necessary to restore blood flow to the affected artery. In more severe cases of cardiogenic shock, mechanical circulatory support devices, such as intra-aortic balloon pumps or extracorporeal membrane oxygenation (ECMO), may be necessary to support cardiac function and maintain blood flow to vital organs. In some cases, surgical intervention, such as coronary artery bypass grafting or valve replacement [4,5].

Early recognition and risk stratification are critical in the management of cardiogenic shock as prompt intervention can improve outcomes. Here are some key points to consider:

Early recognition: The early recognition of cardiogenic shock is essential for prompt intervention. Patients with cardiogenic shock typically present with symptoms such as shortness of breath, chest pain, hypotension, and confusion. Healthcare providers should be vigilant in identifying these symptoms and initiating appropriate diagnostic and treatment measures.

Risk stratification: Once cardiogenic shock is diagnosed, risk stratification can help identify patients who are at higher risk of adverse outcomes. The key factors to consider in risk stratification include the patient's age, comorbidities, severity of shock, and presence of end-organ dysfunction.


Hemodynamic monitoring is essential in the management of cardiogenic shock. It allows clinicians to assess the patient's fluid status, cardiac output, and systemic vascular resistance. Hemodynamic monitoring can help guide therapy and titrate medications to achieve optimal hemodynamic parameters. Treatment options for cardiogenic shock include medical management, mechanical circulatory support, and revascularization. Medical management includes the use of inotropic agents, vasopressors, and diuretics. Mechanical circulatory support, such as intra-aortic balloon pump (IABP) and extracorporeal membrane oxygenation (ECMO), can provide temporary support while the underlying cause of shock is addressed. Revascularization, either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), is the definitive treatment for cardiogenic shock due to acute myocardial infarction [6,7].

During an ECG, electrodes are placed on the patient's chest, arms, and legs, which detect the electrical signals generated by the heart. These signals are then recorded and displayed as a graph, which can be interpreted by a medical professional to evaluate the heart's rhythm, rate, and overall function. ECGs are commonly used to diagnose a variety of heart conditions, including arrhythmias (irregular heartbeats), heart attacks, and heart failure. They can also be used to monitor the effectiveness of heart medications and to assess the risk of future heart problems. Overall, ECGs are a valuable tool for evaluating heart health and diagnosing heart conditions, and they are widely used in medical settings around the world. Echocardiography is a medical imaging technique that uses sound waves to create images of the heart. It is a non-invasive procedure that allows doctors to see the structure and function of the heart in real-time.

Echocardiography is commonly used to diagnose and monitor heart conditions, such as heart failure, valve disease, and congenital heart defects. During an echocardiogram, a technician or doctor applies a gel to the chest and places a transducer (a wand-like device) on the chest. The transducer emits high-frequency sound waves that bounce off the heart and create images of the heart's structures and blood flow patterns. The images are displayed on a monitor and can be recorded for later analysis. Echocardiography can be performed in several ways, including transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), and stress echocardiography.


TTE is the most common type of echocardiography, and it is performed by placing the transducer on the chest. TEE is performed by placing the transducer down the esophagus to get a clearer view of the heart. Stress echocardiography involves exercising the patient to see how their heart responds to stress. Echocardiography is a safe and painless procedure that does not use radiation. It is a valuable tool for diagnosing and monitoring heart conditions and can help doctors make informed decisions about treatment. In conclusion, early recognition and risk stratification are crucial in the management of cardiogenic shock. Hemodynamic monitoring and appropriate treatment options can improve outcomes in these patients. Prompt and coordinated care involving a multidisciplinary team is essential for optimal management of cardiogenic shock.



Conflict of Interest

Authors declare no conflict of interest.


  1. Aissaoui N, et al. Fifteen‐year trends in the management of cardiogenic shock and associated 1‐year mortality in elderly patients with acute myocardial infarction: The FAST‐MI programme. Eur J Heart Fail. 2016;18:1144-1152.
  2. Google Scholar Crossref, Indexed at

  3. Bruoha S, et al. Mechanical circulatory support devices for the treatment of cardiogenic shock complicating acute myocardial infarction – A review. J Clin Med. 2022;11:5241.
  4. Google Scholar, Crossref, Indexed at

  5. Burrell AJ, et al. Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation. J Crit Care. 2015;30:949-956.
  6. Google Scholar, Crossref, Indexed at

  7. Polat N, et al. Prognostic significance of serum albumin in patients with acute coronary syndrome. Angiology. 2020;71:903-908.
  8. Google Scholar, Crossref, Indexed at

  9. Zeymer U, et al. Acute cardiovascular care association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the acute cardiovascular care association of the European society of cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9:183-197.
  10. Google Scholar, Crossref, Indexed at

  11. Thiele H, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699-1710.
  12. Google Scholar, Crossref, Indexed at

  13. Islam MS, et al. Serum albumin level and in-hospital outcome of patients with first attack acute myocardial infarction. Mymensingh Med J. 2019;28:744-751.
  14.  Google Scholar, Indexed at